Abstract
Streptococcus pneumoniae, one of the most common gram-positive pathogens to colonize the human upper respiratory tract, is responsible for many severe infections, including meningitis and bacteremia. A 23-valent pneumococcal vaccine is available to protect against the 23 S. pneumoniae serotypes responsible for 90 of reported bacteremic infections. Unfortunately, current S. pneumoniae serotype testing requires a large panel of expensive antisera, assay results may be subjective, and serotype cross-reactions are common. For this study, we designed an oligonucleotide-based DNA microarray to identify glycosyltransferase gene sequences specific to each vaccine-related serotype. Out of 56 isolates representing different serotypes, only one isolate, representing serotype 23A, was not detected correctly as it could not be distinguished from serotype 23F. Our data suggest that the microarray provides a more cost-effective and reliable way of monitoring pneumococcal capsular types. Copyright © 2011 Yuka Tomita et al.
Cite
CITATION STYLE
Tomita, Y., Okamoto, A., Yamada, K., Yagi, T., Hasegawa, Y., & Ohta, M. (2011). A New microarray system to detect Streptococcus pneumoniae serotypes. Journal of Biomedicine and Biotechnology, 2011. https://doi.org/10.1155/2011/352736
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.